AstraZeneca (AZN)

• Market cap: $206B
• 1 day: -0.50%
• 5 days: 0.56%
• 1 month: -0.15%
• 3 months: -13.75%
• 6 months: -16.47%
• Year to date: -3.07%
• 1 year: -0.30%
• 5 years: 32.95%
• 10 years: 88.25%

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Employees: 89,900

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

45% more call options, than puts

Call options by funds: $485M | Put options by funds: $334M

23% more repeat investments, than reductions

Existing positions increased: 489 | Existing positions reduced: 399

9% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 103

1% more funds holding

Funds holding: 1,197 [Q2] → 1,206 (+9) [Q3]

1.87% less ownership

Funds ownership: 32.98% [Q2] → 31.12% (-1.87%) [Q3]

6% less capital invested

Capital invested by funds: $39.9B [Q2] → $37.6B (-$2.29B) [Q3]

11% less funds holding in top 10

Funds holding in top 10: 18 [Q2] → 16 (-2) [Q3]